Search Results 2021-2030 of 20196 for Receptor

1. Neurosciences Clinical Trials - Medical Professionals

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

2. Medications and supplements that can raise your blood pressure - Mayo Clinic

   Angiotensin II receptor blockers · Angiotensin-converting enzyme (ACE) inhibitors · Anxiety: A cause of high blood pressure? Arteriosclerosis / atherosclerosis.

3. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

   B., a Mayo Clinic cancer researcher, studies a type of cancer therapy called chimeric antigen receptor-T cell therapy, or CAR-T cell therapy. It was hailed ...

4. Discovery's Edge: A Foundation of Cancer Research - Mayo Clinic News Network

   When it pairs up with its receptor partner PD-1 on T cells, the interaction suppresses the immune response.

5. Electromyography (EMG) - Mayo Clinic

   Electromyography (EMG) is a procedure used to diagnose muscle or nerve dysfunction. Learn what to expect from your EMG.

6. Neurology - Clinical trials - Mayo Clinic

   Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

7. Neurology - Clinical trials - Mayo Clinic

   Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

8. A Study to Assess Bone Quality Characteristics, Comparing Type 2 Diabetes Patients who have or have not had Prior Fragile Bone Fractures - Mayo Clinic

   selective E receptor modulators (SERMs);; parathyroid hormone (PTH);; denosumab;; SGL2 inhibitors;; thiazolidinediones. Subjects who have been exposed to a ...

9. A Study Of CTX-712 In Relapsed/Refractory Acute Myeloid Leukemia And Higher Risk Myelodysplastic Syndromes - Mayo Clinic

   History of or chimeric antigen receptor T-cell therapy or other modified T cell therapy. Active, uncontrolled bacterial, fungal, or viral infection ...

10. Tau-tubulin kinase 1: Therapeutic target of Alzheimer's disease - Molecular Neurotherapeutics - Mayo Clinic Research

    Spatial learning impairment, enhanced CDK5/p35 activity and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1.